Does the time since diagnosis affect the quality of life in patients with haematological malignancies at early and late period?

Berrin Balik; Yaşa Gül Mutlu; Ömür Gökmen Sevindik

Makale detayları

Does the time since diagnosis affect the quality of life in patients with haematological malignancies at early and late period?

Yazarlar:

Berrin Balik | Yaşa Gül Mutlu | Ömür Gökmen Sevindik

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Hematoloji

Dergi:

Journal of Medicine and Palliative Care Vol.6 Issue 4, pp.396-402

Belge Tipi:

Makale

Yayın Tarihi:

8/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001357457

pISSN:

2717-7505

Anahtar kelimeler:

Özet:

 Aims: We aimed to determine the quality of life, social support levels and factors affecting patients who were diagnosed with hematological malignancy and received therapy, regarding the certain time points after diagnosis. Turkish version of the EORTC-QLQ-C30 scale is a tool with valid and reliable indicators in assessing the quality of life of patients with hematological cancer. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field. Methods: Turkish version of the EORTC QLQ-C30 v.3.0 was used to assess QoL measures. A total of 89 patients were included and were grouped according to the demographics, diagnostic sub-groups and time elapsed from diagnosis. Results: The scales resulted to be similar across gender and diagnostic groups. When the groups were compared, it was found that the scores in the physical function and role function scales were higher and the scores in the fatigue, loss of appetite, constipation, and diarrhoea scales were lower in younger patients. Constipation was higher in the first 6 months, and no significant difference was observed between groups regarding the remaining QoL measures, interestingly this was also available for a comparison between 1 year period and more. Conclusion: The time from diagnosis had no apperant impact on QoL measures in our patient group. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field.

 Aims: We aimed to determine the quality of life, social support levels and factors affecting patients who were diagnosed with hematological malignancy and received therapy, regarding the certain time points after diagnosis. Turkish version of the EORTC-QLQ-C30 scale is a tool with valid and reliable indicators in assessing the quality of life of patients with hematological cancer. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field. Methods: Turkish version of the EORTC QLQ-C30 v.3.0 was used to assess QoL measures. A total of 89 patients were included and were grouped according to the demographics, diagnostic sub-groups and time elapsed from diagnosis. Results: The scales resulted to be similar across gender and diagnostic groups. When the groups were compared, it was found that the scores in the physical function and role function scales were higher and the scores in the fatigue, loss of appetite, constipation, and diarrhoea scales were lower in younger patients. Constipation was higher in the first 6 months, and no significant difference was observed between groups regarding the remaining QoL measures, interestingly this was also available for a comparison between 1 year period and more. Conclusion: The time from diagnosis had no apperant impact on QoL measures in our patient group. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field.

 Aims: We aimed to determine the quality of life, social support levels and factors affecting patients who were diagnosed with hematological malignancy and received therapy, regarding the certain time points after diagnosis. Turkish version of the EORTC-QLQ-C30 scale is a tool with valid and reliable indicators in assessing the quality of life of patients with hematological cancer. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field. Methods: Turkish version of the EORTC QLQ-C30 v.3.0 was used to assess QoL measures. A total of 89 patients were included and were grouped according to the demographics, diagnostic sub-groups and time elapsed from diagnosis. Results: The scales resulted to be similar across gender and diagnostic groups. When the groups were compared, it was found that the scores in the physical function and role function scales were higher and the scores in the fatigue, loss of appetite, constipation, and diarrhoea scales were lower in younger patients. Constipation was higher in the first 6 months, and no significant difference was observed between groups regarding the remaining QoL measures, interestingly this was also available for a comparison between 1 year period and more. Conclusion: The time from diagnosis had no apperant impact on QoL measures in our patient group. It makes it essential to support our patients throughout the therapy and even after the end of treatment, both medically and socially with experts in the field.

 Giriş: Hematolojik malignite tanısı alan ve kemoterapi alan hastaların yaşam kalitelerini, sosyal destek düzeylerini ve etkileyen faktörleri tanıdan sonra geçen belirli zaman noktalarına göre belirlemeyi amaçladık. EORTC-QLQ-C30 Ölçeğinin Türkçe versiyonu hematolojik kanserli hastaların yaşam kalitesini ölçmede geçerli ve güvenilir göstergelere sahip bir araçtır. Sağlık profesyoneleri, kanser hastalarının yaşam kalitelerinin yanı sıra sağlığının da iyileştirilmesinin önemini göz önünde bulundurmalıdır. Hastaların yaşam kalitesini değerlendirmek için verilerin toplanması ve bakım planlanırken bu verilerden yararlanılması önerilmektedir. Hastalarımıza tedavi boyunca ve hatta tedavi bitiminden sonra da alanında uzman kişilerle hem tıbbi hem de sosyal açıdan destek olmayı gerekli kılmaktadır. Gereç ve Yöntem: Yaşam kalitesi ölçümlerini değerlendirmek için EORTC-QLQ-C30 Türkçe Ölçeği kullanıldı. Toplam 89 hasta dahil edildi ve demografik özelliklerine, tanı alt gruplarına ve tanıdan itibaren geçen süreye göre gruplandırıldı. Sonuçlar: Ölçekler cinsiyet ve tanı grupları arasında benzer sonuçlandı. Yaş grupları karşılaştırıldığında, genç hastalarda fiziksel işlev ve rol işlev ölçek puanlarının daha yüksek, yorgunluk, iştahsızlık, kabızlık ve ishal ölçek puanlarının daha düşük olduğu bulundu. İlk 6 ayda kabızlığın daha fazla olduğu ve kalan QoL ölçümlerinde gruplar arasında anlamlı bir farklılık olmadığı gözlendi, ilginç bir şekilde bu 1 yıl ve üzeri karşılaştırma için de geçerliydi. Sonuç: Hasta grubumuzda tanıdan itibaren geçen sürenin QoL ölçümleri üzerinde belirgin bir etkisi yoktu. Hastalarımıza terapi boyunca ve hatta tedavi bitiminden sonra da alanında uzman kişilerle hem tıbbi hem de sosyal açıdan destek olmayı gerekli kılmaktadır.

Makale detayları

Does the time since diagnosis affect the quality of life in patients with haematological malignancies at early and late period?

Yazarlar:

Berrin Balik | Yaşa Gül Mutlu | Ömür Gökmen Sevindik

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Hematoloji

Dergi:

Journal of Medicine and Palliative Care Vol.6 Issue 4, pp.396-402

Belge Tipi:

Makale

Yayın Tarihi:

8/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001357457

pISSN:

2717-7505

Quality of life

malignancy

haematological

time effectyaşam kalitesi

malignite

hematolojik

zaman etkisi

Sayı

Makale detayları

Yazarlar: Berrin Balik | Yaşa Gül Mutlu | Ömür Gökmen Sevindik

Yayıncı: MediHealth Academy Yayıncılık

Ana Başlıklar: Hematoloji

Dergi: Journal of Medicine and Palliative Care Vol.6 Issue 4, pp.396-402

Belge Tipi: Makale

Yayın Tarihi: 8/2025

Belge Dili: İngilizce

Document ID (Org No.): 2001357457

pISSN: 2717-7505

Sayı

Yazarlar:

Berrin Balik | Yaşa Gül Mutlu | Ömür Gökmen Sevindik

Yayıncı:

MediHealth Academy Yayıncılık

Ana Başlıklar:

Hematoloji

Dergi:

Journal of Medicine and Palliative Care Vol.6 Issue 4, pp.396-402

Belge Tipi:

Makale

Yayın Tarihi:

8/2025

Belge Dili:

İngilizce

Document ID (Org No.):

2001357457

pISSN:

2717-7505